News

News

September 27, 2019
AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference
SAN DIEGO , Sept. 27, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria , chief executive officer of AnaptysBio ,
August 6, 2019
AnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare Conference
SAN DIEGO , Aug. 06, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria , chief executive officer of AnaptysBio , will
May 28, 2019
AnaptysBio to Present at the Jefferies 2019 Healthcare Conference
SAN DIEGO , May 28, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria , chief executive officer of AnaptysBio , will
Displaying 1 - 10 of 13